Bioavailability of MIN 202 in healthy subjects in the US
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Seltorexant (Primary) ; Seltorexant (Primary)
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors Minerva Neurosciences
- 01 Jun 2016 Data from this trial will be presented at the Jefferies 2016 Healthcare Conference, according to a Minerva Neurosciences media release.
- 21 Jan 2015 Preliminary results published in Minerva Neurosciences media release.
- 26 Nov 2014 New trial record